Package 45802-138-18

{"route": ["TOPICAL"], "spl_id": "fc4110cb-f2c4-4f48-8038-023def2c825e", "openfda": {"unii": ["50MD4SB4AP"], "rxcui": ["309289"], "spl_set_id": ["1a74ed86-997a-4b86-b54a-b2b2c94e8abb"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (45802-138-11)  / 30 g in 1 TUBE", "package_ndc": "45802-138-11", "marketing_start_date": "20060719"}, {"sample": false, "description": "1 TUBE in 1 CARTON (45802-138-18)  / 90 g in 1 TUBE", "package_ndc": "45802-138-18", "marketing_start_date": "20061214"}, {"sample": false, "description": "1 TUBE in 1 CARTON (45802-138-35)  / 15 g in 1 TUBE", "package_ndc": "45802-138-35", "marketing_start_date": "20060905"}], "brand_name": "Ciclopirox olamine", "product_id": "45802-138_fc4110cb-f2c4-4f48-8038-023def2c825e", "dosage_form": "CREAM", "pharm_class": ["Decreased DNA Replication [PE]", "Decreased Protein Synthesis [PE]", "Decreased RNA Replication [PE]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "45802-138", "generic_name": "Ciclopirox olamine", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciclopirox olamine", "active_ingredients": [{"name": "CICLOPIROX OLAMINE", "strength": "7.7 mg/g"}], "application_number": "ANDA077364", "marketing_category": "ANDA", "marketing_start_date": "20060719", "listing_expiration_date": "20261231"}